3
Registered trials
1
Recruiting
3
Unique sponsors
2
Unique IMPs
3
Commercial trials
Drug classes (ATC)
—
ATC code not specified
3
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
Phase I:
1
Phase I (First in Human):
2
Phase I
1 trial-
PendingAmgen Inc. CommercialIMP not specified
Phase I (First in Human)
2 trials-
RecruitingIpsen Pharma CommercialIPN01203
-
EndedTakeda Development Center Americas Inc. CommercialTAK-280
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Amgen Inc. | Commercial | 1 | Phase I | 0 |
| Ipsen Pharma | Commercial | 1 | Phase I (First in Human) | 1 |
| Takeda Development Center Americas Inc. | Commercial | 1 | Phase I (First in Human) | 0 |
New trials by year
2024
1
2026
1